These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26925208)

  • 1. Isothiazolo[4,3-
    Li J; Kovackova S; Pu S; Rozenski J; De Jonghe S; Einav S; Herdewijn P
    Medchemcomm; 2015 Sep; 6(9):1666-1672. PubMed ID: 26925208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines.
    Wouters R; Pu SY; Froeyen M; Lescrinier E; Einav S; Herdewijn P; De Jonghe S
    Eur J Med Chem; 2019 Feb; 163():256-265. PubMed ID: 30529544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase.
    Martinez-Gualda B; Pu SY; Froeyen M; Herdewijn P; Einav S; De Jonghe S
    Bioorg Med Chem; 2020 Jan; 28(1):115188. PubMed ID: 31757682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase.
    Martinez-Gualda B; Saul S; Froeyen M; Schols D; Herdewijn P; Einav S; De Jonghe S
    Eur J Med Chem; 2021 Mar; 213():113158. PubMed ID: 33497888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of isothiazolo[4,5-
    Ivanova Y; Spittaels S; Gao LJ; Schols D; Van Meervelt L; Froeyen M; Dehaen W; De Jonghe S
    Org Biomol Chem; 2024 Sep; 22(36):7373-7389. PubMed ID: 39171941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Scaffold-Hopping Strategy toward the Identification of Inhibitors of Cyclin G Associated Kinase.
    Wouters R; Tian J; Herdewijn P; De Jonghe S
    ChemMedChem; 2019 Jan; 14(2):237-254. PubMed ID: 30548533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a 3,7-Disubstituted Isothiazolo[4,3-
    Grisez T; Ravi NP; Froeyen M; Schols D; Van Meervelt L; De Jonghe S; Dehaen W
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.
    Pu SY; Wouters R; Schor S; Rozenski J; Barouch-Bentov R; Prugar LI; O'Brien CM; Brannan JM; Dye JM; Herdewijn P; De Jonghe S; Einav S
    J Med Chem; 2018 Jul; 61(14):6178-6192. PubMed ID: 29953812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents.
    Kovackova S; Chang L; Bekerman E; Neveu G; Barouch-Bentov R; Chaikuad A; Heroven C; Šála M; De Jonghe S; Knapp S; Einav S; Herdewijn P
    J Med Chem; 2015 Apr; 58(8):3393-410. PubMed ID: 25822739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Activities of Pyridine Fused and Pyridine Containing Heterocycles, A Review (from 2000 to 2020).
    Alizadeh SR; Ebrahimzadeh MA
    Mini Rev Med Chem; 2021; 21(17):2584-2611. PubMed ID: 33573543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of dual death-associated protein related apoptosis inducing protein kinase 1 and 2 inhibitors by a scaffold hopping approach.
    Gao LJ; Kovackova S; Sála M; Ramadori AT; De Jonghe S; Herdewijn P
    J Med Chem; 2014 Sep; 57(18):7624-43. PubMed ID: 25178155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK).
    Asquith CRM; Bennett JM; Su L; Laitinen T; Elkins JM; Pickett JE; Wells CI; Li Z; Willson TM; Zuercher WJ
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31698822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity.
    Hao Y; Yang C; Shu C; Li Z; Xia K; Wu S; Ma H; Tian S; Ji Y; Li J; He S; Zhang X
    Bioorg Chem; 2022 Dec; 129():106051. PubMed ID: 36115309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 3-heteroaryl-pyrrolo[2,3-b]pyridines as potent inhibitors of AP-2-associated protein kinase 1 (AAK1) with antiviral activity.
    Ravi NP; Van Eynde W; Karim M; Nhu Tran DH; Agrawal A; Schols D; Voet A; Einav S; Dehaen W; De Jonghe S
    Eur J Med Chem; 2024 Dec; 280():116967. PubMed ID: 39427517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.
    Neveu G; Ziv-Av A; Barouch-Bentov R; Berkerman E; Mulholland J; Einav S
    J Virol; 2015 Apr; 89(8):4387-404. PubMed ID: 25653444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scaffold Hopping Approach to a New Series of Pyridine Derivatives as Potent Inhibitors of CDK2.
    Xu X; Yao Q
    Arch Pharm (Weinheim); 2016 Mar; 349(3):224-31. PubMed ID: 26871934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel CDK inhibitors via scaffold hopping from CAN508.
    Jing L; Tang Y; Xiao Z
    Bioorg Med Chem Lett; 2018 May; 28(8):1386-1391. PubMed ID: 29550093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-
    Mugnaini C; Kostrzewa M; Casini M; Kumar P; Catallo V; Allarà M; Guastaferro L; Brizzi A; Paolino M; Tafi A; Kapatais C; Giorgi G; Vacondio F; Mor M; Corelli F; Ligresti A
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation.
    Jaramillo C; de Diego JE; Hamdouchi C; Collins E; Keyser H; Sánchez-Martínez C; del Prado M; Norman B; Brooks HB; Watkins SA; Spencer CD; Dempsey JA; Anderson BD; Campbell RM; Leggett T; Patel B; Schultz RM; Espinosa J; Vieth M; Zhang F; Timm DE
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6095-9. PubMed ID: 15546737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazo[1,2-a]pyridines: a potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation.
    Anderson M; Beattie JF; Breault GA; Breed J; Byth KF; Culshaw JD; Ellston RP; Green S; Minshull CA; Norman RA; Pauptit RA; Stanway J; Thomas AP; Jewsbury PJ
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3021-6. PubMed ID: 12941325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.